Sanofi is ranked 4th in the multispecialty “Best Pharmaceutical Companies Germany” 2022 ranking in the category “research-based, world-leading pharmaceutical companies by sales”, moving up 6 places compared to the previous year. The first 3 places were taken by Janssen-Cilag, Novartis and Bayer Vital/Jenapharm.
Pfizer wins the “Most Innovative Product” award from general practitioners, practitioners and internists for its COVID-19 drug Paxlovid®. In the inter-specialist ranking “Best Pharmaceutical Companies Germany” 2022, Pfizer comes in 5th place in the category “research-based, world-leading pharmaceutical companies by sales” this year, moving up 5 places compared to the previous year. The first places … [Read more…]
Innovate UK, part of UK Research and Innovation (UKRI), has awarded LabGenius with a SMART grant to accelerate the development of its immune cell engager lead optimization capability LONDON–(BUSINESS WIRE)–#AI–LabGenius, a pioneer in the use of machine learning (ML) for antibody engineering, today announced that it has been awarded a highly competitive SMART grant from … [Read more…]
Internationally, the signing of licensing or distribution partnerships with major players in nutrition and healthcare. In France, Valbiotis has chosen to internalize its commercial operations for direct distribution, in order to generate rapid turnover and to ensure an independent and value-creating source of income. Continued structuring and R&D efforts on natural and scientifically validated active … [Read more…]
CAMBRIDGE, Mass.–(BUSINESS WIRE)–Amylyx Pharmaceuticals, Inc. (“Amylyx”) today announced the pricing of an upsized underwritten public offering of 6,693,750 shares of its common stock at a public offering price of $32.00 per share. All of the shares of common stock are being offered by Amylyx. Amylyx has granted the underwriters a 30-day option to purchase up … [Read more…]
– OXLUMO Now Indicated for the Treatment of Primary Hyperoxaluria Type 1 (PH1) to Lower Urinary and Plasma Oxalate Levels in Pediatric and Adult Patients – – Approval is Based on Positive Efficacy and Safety Results of the ILLUMINATE-C Phase 3 Study of OXLUMO in PH1 Patients with Severe Renal Impairment, Including Those on Hemodialysis … [Read more…]
A preliminary analysis of the University of Oxford’s open label, prospective real-world evidence study, PANORAMIC, conducted in the UK in highly-vaccinated adults mostly <65 years of age, showed no evidence of a difference between LAGEVRIO added to usual care compared to usual care alone for the reduction of hospitalizations and deaths through Day 28 (primary … [Read more…]
Co-Founder of Bonobos and Author Andy Dunn; Television Personality, Model and Best-Selling Author Yolanda Hadid; Morning Brew Co-Founder & Executive Chairman Alex Lieberman and Others to be On-Site Sharing Their Stories in Support of World Mental Health Day NEW YORK–(BUSINESS WIRE)–Project Healthy Minds, a new millennial/Gen Z mental health tech non-profit, is creating a first-of-its-kind … [Read more…]
Boutique Fitness Franchisor Announces a Variety of Charitable Initiatives Across Brands IRVINE, Calif.–(BUSINESS WIRE)–Xponential Fitness (NYSE: XPOF), the largest global curator of boutique fitness brands, is leading the way with contributions to health and wellness causes beyond the four walls of its 2,000-plus studios. Further breaking down barriers and lifting up communities through social efforts, … [Read more…]
BOSTON–(BUSINESS WIRE)–$KRTX–Karuna Therapeutics, Inc. (NASDAQ: KRTX), a clinical-stage biopharmaceutical company driven to create and deliver transformative medicines for people living with psychiatric and neurological conditions, today announced that data from the Phase 3 EMERGENT-2 trial of KarXT in schizophrenia will be shared at the 35th European College of Neuropsychopharmacology (ECNP) Congress, to be held October … [Read more…]
